https://www.selleckchem.com/pr....oducts/jak-inhibitor
The decrease in hydroxyzine initiation in the UK in the 12 months after the advisories was not significantly different for patients with risk factors compared with those without risk factors. Hydroxyzine initiation decreased in the UK, but not in BC, in the 12 months following safety advisories. The decrease in hydroxyzine initiation in the UK was not significantly different for patients with versus without risk factors for QT prolongation and TdP. Hydroxyzine initiation decreased in the UK, but not in BC, in the 12 months follo
Curtir
Comentario
Compartilhar
